Long-Term Remission in Ph-Negative B-ALL With Sequential CAR T, ASCT

This article originally appeared on OncLive®.

Use of a sequential “sandwich” strategy using CD22/CD19 chimeric antigen receptor (CAR) T-cell therapy followed by autologous stem cell transplant (ASCT) resulted in deep and durable remissions…